Literature DB >> 21645613

Repeated recall of learned immunosuppression: evidence from rats and men.

Timo Wirth1, Kirstin Ober, Geraldine Prager, Magdalene Vogelsang, Sven Benson, Oliver Witzke, Andreas Kribben, Harald Engler, Manfred Schedlowski.   

Abstract

Akin to other physiological responses, the immune system can be modified, via Pavlovian or behavioral conditioning. It is unknown, however, whether and to what extent learned immune responses can be repeatedly recalled over time. Here we demonstrate in both rats and humans that repeated contingent pairing of a novel taste (conditioned stimulus, CS) together with the immunosuppressive drug cyclosporine A as unconditioned stimulus (US) leads to the acquisition of a learned immunosuppression. Sole presentation of the CS caused a significant inhibition of interleukin (IL)-2 and interferon (IFN)-γ production by rat splenic T cells and human peripheral T lymphocytes, closely mimicking the effect of the drug. More importantly, a comparable suppression of cytokine production was also observed after a second, unreinforced exposure to the CS that was separated from the first evocation by an interval of 6 (rats) or 11 (humans)days, respectively. Together, our findings demonstrate that a learned immunosuppression can be repeatedly recalled in both animals and humans, which is an important prerequisite for the implementation of conditioning paradigms as supportive therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645613     DOI: 10.1016/j.bbi.2011.05.011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  12 in total

Review 1.  The placebo response in medicine: minimize, maximize or personalize?

Authors:  Paul Enck; Ulrike Bingel; Manfred Schedlowski; Winfried Rief
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

Review 2.  Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy.

Authors:  Ángel Ortega; Juan Salazar; Néstor Galban; Milagros Rojas; Daniela Ariza; Mervin Chávez-Castillo; Manuel Nava; Manuel E Riaño-Garzón; Edgar Alexis Díaz-Camargo; Oscar Medina-Ortiz; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 3.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

4.  Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.

Authors:  Alan Prossin; Alisa Koch; Phillip Campbell; Geoffroy Laumet; Christian S Stohler; Robert Dantzer; Jon-Kar Zubieta
Journal:  Mol Psychiatry       Date:  2021-10-29       Impact factor: 13.437

5.  Complementary and alternative drug therapy versus science-oriented medicine.

Authors:  Manfred Anlauf; Lutz Hein; Hans-Werner Hense; Johannes Köbberling; Rainer Lasek; Reiner Leidl; Bettina Schöne-Seifert
Journal:  Ger Med Sci       Date:  2015-06-23

6.  Placebo effects on the immune response in humans: the role of learning and expectation.

Authors:  Antje Albring; Laura Wendt; Sven Benson; Oliver Witzke; Andreas Kribben; Harald Engler; Manfred Schedlowski
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

7.  Cognitive factors mediate placebo responses in patients with house dust mite allergy.

Authors:  Sabine Vits; Elvir Cesko; Sven Benson; Annika Rueckert; Uwe Hillen; Dirk Schadendorf; Manfred Schedlowski
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

8.  Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses.

Authors:  Laura Wendt; Antje Albring; Sven Benson; Harald Engler; Andrea Engler; Anke Hinney; Winfried Rief; Oliver Witzke; Manfred Schedlowski
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

9.  Learned immunosuppressive placebo responses in renal transplant patients.

Authors:  Julia Kirchhof; Liubov Petrakova; Alexandra Brinkhoff; Sven Benson; Justine Schmidt; Maike Unteroberdörster; Benjamin Wilde; Ted J Kaptchuk; Oliver Witzke; Manfred Schedlowski
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

10.  Conditioning cortisol in humans: design and pilot study of a randomized controlled trial.

Authors:  J Tekampe; H van Middendorp; F C G J Sweep; S H P P Roerink; A R M M Hermus; A W M Evers
Journal:  Pilot Feasibility Stud       Date:  2019-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.